**7. References**


Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age 415

Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C and Frangione B (1995).

Chapman J, Korczyn AD, Karussis DM and Michaelson DM (2001). The effects of APOE

Chin J, Palop JJ, Puolivali J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E

Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes

Cooper GM and Shendure J (2011). Needles in stacks of needles: finding disease-causal

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD,

Courtney E, Kornfeld S, Janitz K and Janitz M (2010). Transcriptome profiling in

Cuijpers P (2005). Depressive disorders in caregivers of dementia patients: a systematic

Cullen KM and Halliday GM (1998). Neurofibrillary degeneration and cell loss in the

Cummings J (2010). What can be inferred from the interruption of the semagacestat trial for

D'Andrea MR and Nagele RG (2010). Morphologically distinct types of amyloid plaques

D'Andrea MR, Nagele RG, Wang HY, Peterson PA and Lee DH (2001). Evidence that

Davis DG, Schmitt FA, Wekstein DR and Markesbery WR (1999). Alzheimer

Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF,

Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu

differentiated into motor neurons. *Science* 321(5893): 1218-1221.

variants in a wealth of genomic data. *Nat Rev Genet* 12(9): 628-640.

neurodegenerative disease*. J Neurosci Methods* 193(2): 189-202.

treatment of Alzheimer's disease? *Biol Psychiatry* 68(10): 876-878.

Alzheimer's disease. *Histopathology* 38(2): 120-134.

E*. Biochem J* 306 ( Pt 2): 599-604.

nucleotide resolution. *Genome Biol* 9(9): 234.

review. *Aging Ment Health* 9(4): 325-330.

*Biotech Histochem* 85(2): 133-147.

*Neurol* 58(4): 376-388.

5(5): 452-457.

57(8): 1482-1485.

464(7289): 704-712.

921-923.

19(4): 297-306.

Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein

genotype on age at onset and progression of neurodegenerative diseases. *Neurology*

and Mucke L (2005). Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. *J Neurosci* 25(42): 9694-9703. Cloonan N and Grimmond SM (2008). Transcriptome content and dynamics at single-

C, Campbell P, Fitzgerald T, Hu M, Ihm CH, Kristiansson K, Macarthur DG, Macdonald JR, Onyiah I, Pang AW, Robson S, Stirrups K, Valsesia A, Walter K, Wei J, Tyler-Smith C, Carter NP, Lee C, Scherer SW and Hurles ME (2010). Origins and functional impact of copy number variation in the human genome. *Nature*

Haines JL and Pericak-Vance MA (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. *Science* 261(5123):

nucleus basalis in comparison to cortical Alzheimer pathology. *Neurobiol Aging*

point the way to a better understanding of Alzheimer's disease pathogenesis.

neurones accumulating amyloid can undergo lysis to form amyloid plaques in

neuropathologic alterations in aged cognitively normal subjects. *J Neuropathol Exp* 

Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE and Eggan K (2008). Induced pluripotent stem cells generated from patients with ALS can be

X, Holtzman DM and Paul SM (2002). Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. *Nat Neurosci*

DR, Licinio J, Manca MC, Marshall PA, Matsuda I, Ngare D, Wang VO, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng C, Brooks LD and McEwen JE (2010). Integrating common and rare genetic variation in diverse human populations. *Nature* 467(7311): 52-58.


Alzheimer A (1907). Ueber eine eigenartige Erkrankung der Himrinde. *Allg. Z. Psychiat.* 

Alzheimer A (1911). Ueber eigenartige Krankheitsfalle des spateren *Alters. Z. Ges. Neurol.* 

Alzheimer's Disease International (2009). World Alzheimer Report 2010. Prince M. London. Alzheimer's Disease International (2010). 2010 Alzheimer's disease facts and figures.

Ashford JW (2004). APOE genotype effects on Alzheimer's disease onset and epidemiology.

Atwal JK, Chen Y, Chiu C, Mortensen DL, Meilandt WJ, Liu Y, Heise CE, Hoyte K, Luk W,

Belbin O, Dunn JL, Ling Y, Morgan L, Chappell S, Beaumont H, Warden D, Smith DA,

Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B,

Birks J (2006). Cholinesterase inhibitors for Alzheimer's disease. *Cochrane Database Syst* 

Blennow K and Hampel H (2003). CSF markers for incipient Alzheimer's disease. *Lancet* 

Braak H and Braak E (1991). Neuropathological stageing of Alzheimer-related changes. *Acta* 

Braak H and Braak E (1997). Frequency of stages of Alzheimer-related lesions in different

Brookmeyer R, Johnson E, Ziegler-Graham K and Arrighi HM (2007). Forecasting the global

Buckner RL, Andrews-Hanna JR and Schacter DL (2008). The brain's default network: anatomy, function, and relevance to disease. *Ann N Y Acad Sci* 1124: 1-38.

burden of Alzheimer's disease. *Alzheimers Demen*t 3(3): 186-191.

susceptibility loci in addition to APOE. *Am J Hum Genet* 83(5): 623-632. Bertram L, McQueen MB, Mullin K, Blacker D and Tanzi RE (2007). Systematic meta-

Alzheimer's disease. *Hum Mol Genet* 16(18): 2199-2208.

Lu Y, Peng K, Wu P, Rouge L, Zhang Y, Lazarus RA, Scearce-Levie K, Wang W, Wu Y, Tessier-Lavigne M and Watts RJ (2011). A therapeutic antibody targeting BACE1 inhibits amyloid-beta production in vivo*. Sci Transl Med* 3(84): 84ra43. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little

SP, Cummins DJ, Piccardo P, Ghetti B and Paul SM (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. *Nat Genet* 17(3): 263-264. Beach TG and McGeer EG (1988). Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex. *Brain Res* 463(2): 357-361. Bekris LM, Yu CE, Bird TD and Tsuang DW (2010). Genetics of Alzheimer disease. *J Geriatr* 

Kalsheker N and Morgan K (2007). Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in

Divito J, Ionita I, Jiang H, Laird N, Moscarillo T, Ohlsen KL, Elliott K, Wang X, Hu-Lince D, Ryder M, Murphy A, Wagner SL, Blacker D, Becker KD and Tanzi RE (2008). Genome-wide association analysis reveals putative Alzheimer's disease

analyses of Alzheimer disease genetic association studies: the AlzGene database.

*Nature* 467(7311): 52-58.

*Med*. 64: 146-148.

*Psychiat*. 4: 356-385.

*Alzheimers Dement* 6(2): 158-194.

*Psychiatry Neurol* 23(4): 213-227.

*Nat Genet* 39(1): 17-23.

*Neurol* 2(10): 605-613.

*Neuropathol* (Berl) 82(4): 239-259.

age categories*. Neurobiol Aging* 18(4): 351-357.

*Rev*(1): CD005593.

*J Mol Neurosci* 23(3): 157-165.

DR, Licinio J, Manca MC, Marshall PA, Matsuda I, Ngare D, Wang VO, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng C, Brooks LD and McEwen JE (2010). Integrating common and rare genetic variation in diverse human populations.


Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age 417

Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM,

Gotz J, Chen F, van Dorpe J and Nitsch RM (2001). Formation of neurofibrillary tangles in

Gotz J and Ittner LM (2008). Animal models of Alzheimer's disease and frontotemporal

Gotz J, Probst A, Spillantini MG, Schafer T, Jakes R, Burki K and Goedert M (1995).

Gouras GK, Tampellini D, Takahashi RH and Capetillo-Zarate E (2010). Intraneuronal beta-

Graeber MB, Kosel S, Egensperger R, Banati RB, Muller U, Bise K, Hoff P, Moller HJ,

Graeber MB, Kosel S, Grasbon-Frodl E, Moller HJ and Mehraein P (1998). Histopathology

Graeber MB and Streit WJ (2010). Microglia: biology and pathology. *Acta Neuropathol* 119(1):

Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, Tschape JA, De

Grosgen S, Grimm MO, Friess P and Hartmann T (2010). Role of amyloid beta in lipid

Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R,

Gravitz L (2011). Drugs: a tangled web of targets. *Nature* 475(7355): S9-11.

homeostasis. *Biochim Biophys Acta* 1801(8): 966-974.

Alzheimer disease. *Arch Neurol* 57(6): 831-836.

76(11): 1006-1014.

1304-1313.

89-105.

1118-1123.

*Neuropathol* 119(5): 523-541.

*Neurogenetics* 1(1): 73-80.

Neurogenetics 1(3): 223-228.

dementia. *Nat Rev Neurosci* 9(7): 532-544.

Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM and Grossman M (2011). Classification of primary progressive aphasia and its variants. *Neurology*

P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293(5534): 1491-1495.

Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. *EMBO J* 14(7):

amyloid accumulation and synapse pathology in Alzheimer's disease. *Acta* 

Fujisawa K and Mehraein P (1997). Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis.

and APOE genotype of the first Alzheimer disease patient, Auguste D.

Strooper B, Muller U, Shen J and Hartmann T (2005). Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. *Nat Cell Biol* 7(11):

Stone D, Schadt E, Karnoub M, Nowotny P, Tacey K, Catanese J, Sninsky J, Brayne C, Rubinsztein D, Gill M, Lawlor B, Lovestone S, Holmans P, O'Donovan M, Morris JC, Thal L, Goate A, Owen MJ and Williams J (2007). Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. *Hum Mol Genet* 16(8): 865-873. Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe

CC, Szoeke C, Taddei K and Martins RN (2011). Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. *Neurology* 76(12): 1091-1098. Halliday GM, Double KL, Macdonald V and Kril JJ (2003). Identifying severely atrophic cortical subregions in Alzheimer's disease. *Neurobiol Aging* 24(6): 797-806. Halliday GM, Shepherd CE, McCann H, Reid WG, Grayson DA, Broe GA and Kril JJ (2000).

Effect of anti-inflammatory medications on neuropathological findings in

and safety of donepezil, galantamine, and rivastigmine for the treatment of

Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG and Jonas DE (2008). Efficacy


Dubois B and Albert ML (2004). Amnestic MCI or prodromal Alzheimer's disease? *Lancet* 

Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF,

Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D and Heyman A (1996). Cerebral

Enard W, Khaitovich P, Klose J, Zollner S, Heissig F, Giavalisco P, Nieselt-Struwe K,

Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA and Gage

Finehout EJ, Franck Z, Choe LH, Relkin N and Lee KH (2007). Cerebrospinal fluid proteomic

Fukumoto H, Ingelsson M, Garevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M,

Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens

Gauthier S, Loft H and Cummings J (2008). Improvement in behavioural symptoms in

Giaccone G, Pedrotti B, Migheli A, Verga L, Perez J, Racagni G, Smith MA, Perry G, De

and neurofibrillary tangles in Alzheimer's disease. *Am J Pathol* 148(1): 79-87. Glenner GG and Wong CW (1984). Alzheimer's disease and Down's syndrome: sharing of a

Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes

Gold PE (2003). Acetylcholine modulation of neural systems involved in learning and

Golde TE, Schneider LS and Koo EH (2011). Anti-abeta therapeutics in Alzheimer's disease:

Gomez-Isla T, Price JL, McKeel DW, Jr., Morris JC, Growdon JH and Hyman BT (1996).

biomarkers for Alzheimer's disease. *Ann Neurol* 61(2): 120-129.

Gandy S (2011). Perspective: prevention is better than cure. *Nature* 475(7355): S15.

analysis. *Int J Geriatr Psychiatry* 23(5): 537-545.

memory. *Neurobiol Learn Mem* 80(3): 194-210.

disease. *J Neurosci* 16(14): 4491-4500.

the need for a paradigm shift*. Neuron* 69(2): 203-213.

Fox N, Kennedy A, Rossor M and Brooks DJ (2008). Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET

amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD

Muchmore E, Varki A, Ravid R, Doxiadis GM, Bontrop RE and Paabo S (2002). Intra- and interspecific variation in primate gene expression patterns. *Science*

FH (1998). Neurogenesis in the adult human hippocampus. *Nat Med* 4(11): 1313-

Hyman BT, Rebeck GW and Irizarry MC (2003). APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. *Exp Neurol*

J, Donaldson T, Gillespie F and et al. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. *Nature*

patients with moderate to severe Alzheimer's disease by memantine: a pooled data

Gioia L, Selvaggini C, Salmona M, Ghiso J, Frangione B, Islam K, Bugiani O and Tagliavini F (1996). beta PP and Tau interaction. A possible link between amyloid

unique cerebrovascular amyloid fibril protein. *Biochem Biophys Res Commun* 122(3):

A, Irving N, James L and et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. *Nature*

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's

*Neurol* 3(4): 246-248.

296(5566): 340-343.

183(1): 249-253.

373(6514): 523-527.

1131-1135.

349(6311): 704-706.

1317.

study. *Neurobiol Dis* 32(3): 412-419.

experience, Part XV. *Neurology* 46(6): 1592-1596.


Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age 419

CD2AP are associated with Alzheimer's disease. *Nat Genet* 43(5): 429-435. Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B,

Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S,

Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F,

Hyman BT and Trojanowski JQ (1997). Consensus recommendations for the postmortem

assessment of Alzheimer disease. *J Neuropathol Exp Neurol* 56(10): 1095-1097. Innamorato NG, Lastres-Becker I and Cuadrado A (2009). Role of microglial redox balance in modulation of neuroinflammation. *Curr Opin Neurol* 22(3): 308-314. International Human Genome Sequencing Consortium (2004). Finishing the euchromatic

Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie

Jack CR, Jr., Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B and

Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P,

Alzheimer's disease. *Proc Natl Acad Sci U S A* 97(6): 2892-2897.

with the inherited dementia FTDP-17. *Nature* 393(6686): 702-705.

biomarkers for Alzheimer's disease. *Brain* 129(Pt 11): 3042-3050.

sequence of the human genome. *Nature* 431(7011): 931-945.

Alzheimer's disease. *Alzheimers Dement* 7(3): 257-262.

Models. *Cell* 142(3): 387-397.

408(6815): 979-982.

Olney J, McKeel D, Wozniak D and Paul SM (2000). Apolipoprotein E isoformdependent amyloid deposition and neuritic degeneration in a mouse model of

Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T and Heutink P (1998). Association of missense and 5'-splice-site mutations in tau

Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P, Ward M and Lovestone S (2006). Proteome-based plasma

diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological

MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E and Gotz J (2010). Dendritic Function of Tau Mediates Amyloid-beta Toxicity in Alzheimer's Disease Mouse

Phelps CH (2011). Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for

Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P and Westaway D (2000). A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. *Nature*

Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P and Williams J (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and

Alzheimer's disease: a systematic review and meta-analysis. *Clin Interv Aging* 3(2): 211-225.


Hardy J and Selkoe DJ (2002). The amyloid hypothesis of Alzheimer's disease: progress and

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS,

Haroutunian V, Hoffman LB and Beeri MS (2009). Is there a neuropathology difference

Herukka SK, Hallikainen M, Soininen H and Pirttila T (2005). CSF Abeta42 and tau or

Heston LL (1977). Alzheimer's disease, trisomy 21, and myeloproliferative disorders: associations suggesting a genetic diathesis. *Science* 196(4287): 322-323. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I,

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R,

between mild cognitive impairment and dementia? *Dialogues Clin Neurosci* 11(2):

phosphorylated tau and prediction of progressive mild cognitive impairment.

Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K and Duff K (1998). Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin

Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MM, Ikram MA, Destefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C,

problems on the road to therapeutics. *Science* 297(5580): 353-356.

211-225.

171-179.

*Nat Genet* 41(10): 1088-1093.

*Neurology* 64(7): 1294-1297.

1 transgenes*. Nat Med* 4(1): 97-100.

Alzheimer's disease: a systematic review and meta-analysis. *Clin Interv Aging* 3(2):

Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ and Williams J (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P and Williams J (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. *Nat Genet* 43(5): 429-435.


Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age 421

human genome. *Nature* 409(6822): 860-921.

*PLoS Biol* 5(10): e254.

*Science* 293(5534): 1487-1491.

Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP, Axelrod N, Huang J, Kirkness EF,

Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro

Lewis DA, Campbell MJ, Terry RD and Morrison JH (1987). Laminar and regional

Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-

familial Alzheimer's disease locus*. Science* 269(5226): 973-977.

Denisov G, Lin Y, Macdonald JR, Pang AW, Shago M, Stockwell TB, Tsiamouri A, Bafna V, Bansal V, Kravitz SA, Busam DA, Beeson KY, McIntosh TC, Remington KA, Abril JF, Gill J, Borman J, Rogers YH, Frazier ME, Scherer SW, Strausberg RL and Venter JC (2007). The Diploid Genome Sequence of an Individual Human.

PD, Schmidt SD, Wang K and et al. (1995). Candidate gene for the chromosome 1

distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 7(6): 1799-1808. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L,

Yager D, Eckman C, Hardy J, Hutton M and McGowan E (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P and Hutton M (2000). Neurofibrillary tangles,

Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S and Chen YJ (2001). Initial sequencing and analysis of the


Jick H, Zornberg GL, Jick SS, Seshadri S and Drachman DA (2000). Statins and the risk of

Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR, Martins RA, Kennedy

Johnson JK, Head E, Kim R, Starr A and Cotman CW (1999). Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 56(10): 1233-1239. Jorm AF and Jolley D (1998). The incidence of dementia: a meta-analysis. *Neurology* 51(3):

Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G,

Krause DL and Muller N (2010). Neuroinflammation, microglia and implications for anti-

Kril JJ (2009). Alzheimer disease: Alzheimer disease neuropathology in the oldest old. *Nat* 

Kril JJ and Halliday GM (2001). Alzheimer's disease: its diagnosis and pathogenesis*. Int Rev* 

Kril JJ, Patel S, Harding AJ and Halliday GM (2002). Neuron loss from the hippocampus of

Kurochkin IV and Goto S (1994). Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. *FEBS Lett* 345(1): 33-37. LaFerla FM, Green KN and Oddo S (2007). Intracellular amyloid-beta in Alzheimer's

Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika

Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K,

Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S,

association study of hypertriglyceridemia. *Nat Genet* 42(8): 684-687.

BA, Hassell RG, Visser ME, Schwartz SM, Voight BF, Elosua R, Salomaa V, O'Donnell CJ, Dallinga-Thie GM, Anand SS, Yusuf S, Huff MW, Kathiresan S and Hegele RA (2010). Excess of rare variants in genes identified by genome-wide

Beyreuther K and Muller-Hill B (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325(6106): 733-736. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE,

Dickson DW, Johnson KA, Petersen LE, McDonald WC, Braak H and Petersen RC (2003). Neuropathology of cognitively normal elderly. *J Neuropathol Exp Neurol*

inflammatory treatment in Alzheimer's disease. *Int J Alzheimer Dis*. 2010; 2010:

Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. *Acta* 

D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M and Amouyel P (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. *Nat Genet*

dementia. *Lancet* 356(9242): 1627-1631.

728-733.

732806.

62(11): 1087-1095.

*Rev Neurol* 5(8): 411-412.

*Neuropathol* 103(4): 370-376.

disease. *Nat Rev Neurosci* 8(7): 499-509.

*Neurobiol* 48: 167-217.

41(10): 1094-1099.

Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S and Chen YJ (2001). Initial sequencing and analysis of the human genome. *Nature* 409(6822): 860-921.


Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age 423

Morgan K (2011). The three new pathways leading to Alzheimer's disease. *Neuropathol Appl* 

Mullis KB and Faloona FA (1987). Specific synthesis of DNA in vitro via a polymerase-

Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD,

Nathans D and Smith HO (1975). Restriction endonucleases in the analysis and restructuring

Nee LE, Polinsky RJ, Eldridge R, Weingartner H, Smallberg S and Ebert M (1983). A family with histologically confirmed Alzheimer's disease*. Arch Neurol* 40(4): 203-208. Newell KL, Hyman BT, Growdon JH and Hedley-Whyte ET (1999). Application of the

Nuutinen T, Suuronen T, Kauppinen A and Salminen A (2009). Clusterin: a forgotten player

Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson

Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B,

National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. *J Neuropathol Exp Neurol* 58(11):

MP, Akbari Y and LaFerla FM (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

Eisner L, Flitman S, Michel BF, Boada M, Frank A and Hock C (2003). Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.

of dna molecules. *Annu Rev Biochem* 44: 273-293.

in Alzheimer's disease. *Brain Res Rev* 61(2): 89-104.

Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, George-Hyslop PS, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, Decarli C, Dekosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA and Schellenberg GD (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease*. Nat* 

catalyzed chain reaction. *Methods Enzymol* 155: 335-350.

*Neurobiol* 37(4): 353-357.

*Genet* 43(5): 436-441.

*Neuron* 39(3): 409-421.

*Neurology* 61(1): 46-54.

1147-1155.

amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. *Nat Genet* 25(4): 402-405.


Lorenzo A and Yankner BA (1994). Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. *Proc Natl Acad Sci U S A* 91(25): 12243-12247. Lue LF, Brachova L, Civin WH and Rogers J (1996). Inflammation, A beta deposition, and

Lupton MK, Proitsi P, Danillidou M, Tsolaki M, Hamilton G, Wroe R, Pritchard M, Lord K,

Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman

Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL and Beyreuther K (1985).

Mattick JS (2011). The central role of RNA in human development and cognition*. FEBS Lett*

Mattick JS, Taft RJ and Faulkner GJ (2010). A global view of genomic information--moving beyond the gene and the master regulator. *Trends Genet* 26(1): 21-28. Maurer K, Volk S and Gerbaldo H (1997). Auguste D and Alzheimer's disease. *Lancet* 

Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE

McKhann G, Drachman D, Folstein M, Katzman R, Price D and Stadlan EM (1984). Clinical

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, Klunk WE,

McShane R, Areosa Sastre A and Minakaran N (2006). Memantine for dementia. *Cochrane* 

Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R and Quack G (2002). Neuroprotection by

neurodegeneration. *J Neuropathol Exp Neurol* 55(10): 1083-1088.

high-density picolitre reactors. *Nature* 437(7057): 376-380.

tau protein. *Nat Genet* 25(4): 402-405.

disease. *PLoS One* 6(2): e17298.

*Acad Sci U S A* 82(12): 4245-4249.

disease. *Science* 330(6012): 1774.

*Database Syst Rev(2)*: CD003154.

958(1): 210-221.

Alzheimer's Disease. *Neurology* 34(7): 939-944.

Alzheimer's disease. *Alzheimers Dement* 7(3): 263-269.

585(11): 1600-1616.

349(9064): 1546-1549.

amyotrophy and progressive motor disturbance in mice expressing mutant (P301L)

neurofibrillary tangle formation as correlates of Alzheimer's disease

Martin BM, Kloszewska I, Soininen H, Mecocci P, Vellas B, Harold D, Hollingworth P, Lovestone S and Powell JF (2011). Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's

MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer ML, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF and Rothberg JM (2005). Genome sequencing in microfabricated

Amyloid plaque core protein in Alzheimer disease and Down syndrome. *Proc Natl* 

and Bateman RJ (2010). Decreased clearance of CNS beta-amyloid in Alzheimer's

diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on

Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S and Phelps CH (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for

memantine against neurodegeneration induced by beta-amyloid(1-40). *Brain Res*


Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age 425

Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ and

deficits in an Alzheimer's disease mouse model. *Science* 316(5825): 750-754. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C,

Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H,

Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA and Arnheim N (1985).

analysis for diagnosis of sickle cell anemia. *Science* 230(4732): 1350-1354. Sanger F, Nicklen S and Coulson AR (1977). DNA sequencing with chain-terminating

Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-

Shepherd C, McCann H and Halliday GM (2009). Variations in the neuropathology of

Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C and

Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW,

Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O,

Somorjai RL, Dolenko B and Baumgartner R (2003). Class prediction and discovery using

Southern EM (1975). Detection of specific sequences among DNA fragments separated by

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Jr.,

Wharton SB (2010). Astrocyte phenotype in relation to Alzheimer-type pathology

Lombroso PJ, Gouras GK and Greengard P (2005). Regulation of NMDA receptor

Mitalipova M, Isacson O and Jaenisch R (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. *Cell* 136(5): 964-

gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions.

Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV and Phelps CH (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations

familial Alzheimer's disease. *Acta Neuropathol* 118(1): 37-52.

trafficking by amyloid-beta. *Nat Neurosci* 8(8): 1051-1058.

in the ageing brain*. Neurobiol Aging* 31(4): 578-590.

*Bioinformatics* 19(12): 1484-1491.

gel electrophoresis. *J Mol Biol* 98(3): 503-517.

977.

with cerebral amyloid angiopathy*. Nat Genet* 38(1): 24-26.

(AIBL) study of aging. *Neurobiol Aging* 31(8): 1275-1283.

inhibitors. *Proc Natl Acad Sci U S A* 74(12): 5463-5467.

*Lancet Neurol* 9(4): 363-372.

bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

Mucke L (2007). Reducing endogenous tau ameliorates amyloid beta-induced

Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T and Campion D (2006). APP locus duplication causes autosomal dominant early-onset Alzheimer disease

Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D and Villemagne VL (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle

Enzymatic amplification of beta-globin genomic sequences and restriction site

Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D and Seubert P (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. *Nature* 400(6740): 173-177. Schneider LS, Dagerman KS, Higgins JP and McShane R (2011). Lack of evidence for the efficacy of memantine in mild Alzheimer disease. *Arch Neurol* 68(8): 991-998. Schottky J (1932). Ueber praesenile Verbloedungen. Z. Ges. Neurol. Psychiat. 140: 333-397. Selkoe DJ (2002). Alzheimer's disease is a synaptic failure. *Science* 298(5594): 789-791.


Pan Q, Shai O, Lee LJ, Frey BJ and Blencowe BJ (2008). Deep surveying of alternative

Pareek CS, Smoczynski R and Tretyn A (2011). Sequencing technologies and genome

Perlmutter LS, Barron E and Chui HC (1990). Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 119(1): 32-36. Perusini G (1909). Über klinisch und histologisch eigenartige psychische Erkrankungen des

Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind

Preece P and Cairns NJ (2003). Quantifying mRNA in postmortem human brain: influence of

Price JL, McKeel DW, Jr., Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA,

Pritchard JK (2001). Are rare variants responsible for susceptibility to complex diseases? *Am* 

Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L and Oremus

Ramskold D, Wang ET, Burge CB and Sandberg R (2009). An abundance of ubiquitously

Rapoport M, Dawson HN, Binder LI, Vitek MP and Ferreira A (2002). Tau is essential to beta -amyloid-induced neurotoxicity. *Proc Natl Acad Sci U S A* 99(9): 6364-6369. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD,

Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S,

polymorphism on brain ApoE levels. *J Neurosci* 28(45): 11445-11453. Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K,

Postina R (2008). A closer look at alpha-secretase. *Curr Alzheimer Res* 5(2): 179-186.

preclinical Alzheimer disease. *Neurobiol Aging* 30(7): 1026-1036.

mRNA variance. *Brain Res Mol Brain Res* 118(1-2): 60-71.

*Nat Genet* 40(12): 1413-1415.

sequencing. *J Appl Genet.*

*Alzheimer* A: 297-351.

cognition. *Arch Neurol* 63(7): 936-939.

*J Hum Genet* 69(1): 124-137.

carriers. *Neuron* 54(5): 713-720.

379-397.

5(12): e1000598.

splicing complexity in the human transcriptome by high-throughput sequencing.

späteren Lebensalters. Histologische und Histopathologische Arbeiten. *Nissl F and* 

MA, Schellenberg GD, Lee VM and Galasko DR (2006). Age and apolipoprotein E\*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal

gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe

Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W and Morris JC (2009). Neuropathology of nondemented aging: presumptive evidence for

M (2008). Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. *Ann Intern Med* 148(5):

expressed genes revealed by tissue transcriptome sequence data. *PLoS Comput Biol*

Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A and Stephan DA (2007). GAB2 alleles modify Alzheimer's risk in APOE epsilon4

Kirksey Y, Hu Y, Wagner E, Parratt A, Xu J, Li Z, Zaleska MM, Jacobsen JS, Pangalos MN and Reinhart PH (2008). Impact of apolipoprotein E (ApoE)

Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg KM, Schenk D, Black R and Grundman M (2010). 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. *Lancet Neurol* 9(4): 363-372.


Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age 427

Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M,

Vlad SC, Miller DR, Kowall NW and Felson DT (2008). Protective effects of NSAIDs on the

Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ and Selkoe DJ (2002). Amyloid-beta

Wan Y, Kertesz M, Spitale RC, Segal E and Chang HY (2011). Understanding the transcriptome through RNA structure. *Nat Rev Genet* 12(9): 641-655. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP

oligomers: their production, toxicity and therapeutic inhibition. *Biochem Soc Trans*

and Burge CB (2008). Alternative isoform regulation in human tissue

development of Alzheimer disease. *Neurology* 70(19): 1672-1677.

transcriptomes. *Nature* 456(7221): 470-476.

1351.

30(4): 552-557.

Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A and Zhu X (2001). The sequence of the human genome. *Science* 291(5507): 1304-

from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. *Alzheimers Dement* 7(3): 280-292.


Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M,

Sutherland GT, Janitz M and Kril JJ (2011a). Understanding the pathogenesis of Alzheimer's

Sutherland GT and Sidhu KS (2011). Pluripotent Stem Cells for (Neurodegenerative) Disease

Sutherland GT, Siebert GA, Kril JJ and Mellick GD (2011b). Knowing Me, Knowing You:

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S (2007).

Tanzi RE (1989). Molecular genetics of Alzheimer's disease and the amyloid beta peptide

Tanzi RE, Bird ED, Latt SA and Neve RL (1987a). The amyloid beta protein gene is not

Tanzi RE, St George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin JF, Neve RL,

Terry RD and Katzman R (1983). Senile dementia of the Alzheimer type. *Ann Neurol* 14(5):

The 1000 Genomes Project Consortium (2010). A map of human genome variation from

The Huntington's Disease Collaborative Research Group (1993). A novel gene containing a

Troncoso JC, Martin LJ, Dal Forno G and Kawas CH (1996). Neuropathology in controls and

Twine NA, Janitz K, Wilkins MR and Janitz M (2011). Whole transcriptome sequencing

Vassar R, Kovacs DM, Yan R and Wong PC (2009). The beta-secretase enzyme BACE in

population-scale sequencing. *Nature* 467(7319): 1061-1073.

Alzheimer's disease*. PLoS One* 6(1): e16266.

potential*. J Neurosci* 29(41): 12787-12794.

*Bench-To-Bedside*. Sidhu KS, Bentham Press. (under publication).

1004-1010.

8102.

937-946.

395-415

669.

497-506.

971-983.

factors. *Cell* 131(5): 861-872.

329(6135): 156-157.

*Aging* 17(3): 365-371.

precursor gene. *Ann Med* 21(2): 91-94.

from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. *Alzheimers Dement* 7(3): 280-292. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D and Mayeux R (1994). Influence of

education and occupation on the incidence of Alzheimer's disease. *Jama* 271(13):

Schmechel D, Saunders AM, Goldgaber D and Roses AD (1993). Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. *Proc Natl Acad Sci U S A* 90(17): 8098-

disease: will RNA-Seq realize the promise of transcriptomics*? J Neurochem* 116(6):

Modelling. *Frontiers in Pluripotent Stem Cells Research and Therapeutic Potentials;* 

Can Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease? *J Alzheimers Dis*. 25(3):

Induction of pluripotent stem cells from adult human fibroblasts by defined

duplicated in brains from patients with Alzheimer's disease. *Science* 238(4827): 666-

McClatchey AI, Conneally PM and Gusella JF (1987b). The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene*. Nature*

trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. *Cell* 72(6):

demented subjects from the Baltimore Longitudinal Study of Aging. *Neurobiol* 

reveals gene expression and splicing differences in brain regions affected by

health and Alzheimer's disease: regulation, cell biology, function, and therapeutic


Weiner MW, Aisen PS, Jack CR, Jr., Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris

Weisgraber KH, Innerarity TL and Mahley RW (1982). Abnormal lipoprotein receptor-

Weller RO, Subash M, Preston SD, Mazanti I and Carare RO (2008). Perivascular drainage of

Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF and

Wolozin B, Kellman W, Ruosseau P, Celesia GG and Siegel G (2000). Decreased prevalence

Yoshikai S, Sasaki H, Doh-ura K, Furuya H and Sakaki Y (1990). Genomic organization of the human amyloid beta-protein precursor gene. *Gene* 87(2): 257-263. Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, Atwal J, Elliott JM, Prabhu S, Watts RJ

Zellner M, Veitinger M and Umlauf E (2009). The role of proteomics in dementia and

angiopathy and Alzheimer's disease. *Brain Pathol* 18(2): 253-266.

its affinity for a transcytosis target. *Sci Transl Med* 3(84): 84ra44.

a single site. *J Biol Chem* 257(5): 2518-2521.

of dementia in 2005. *Alzheimers Dement* 3(2): 81-91.

reductase inhibitors. *Arch Neurol* 57(10): 1439-1443.

Alzheimer's disease. *Acta Neuropathol* 118(1): 181-195.

JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE and Schmidt M (2010). The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement 6(3): 202-211 e207.

binding activity of the human E apoprotein due to cysteine-arginine interchange at

amyloid-beta peptides from the brain and its failure in cerebral amyloid

Williams KL (1996). Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. *Biotechnol Genet Eng Rev* 13: 19-50. Wimo A, Winblad B and Jonsson L (2007). An estimate of the total worldwide societal costs

of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A

and Dennis MS (2011). Boosting brain uptake of a therapeutic antibody by reducing
